Enliven Therapeutics
ELVN
#5218
Rank
NZ$1.95 B
Marketcap
$41.28
Share price
5.84%
Change (1 day)
80.91%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$35.73 M

According to Enliven Therapeutics's latest financial reports the company's total liabilities are NZ$35.73 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$41.05 M-83.72%
2022-12-31NZ$0.25 B10.56%
2021-12-31NZ$0.22 B8.42%
2020-12-31NZ$0.21 B